{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:31:51Z","timestamp":1784694711023,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100015286","name":"Hebei Provincial Key Research Projects","doi-asserted-by":"publisher","award":["20230797"],"award-info":[{"award-number":["20230797"]}],"id":[{"id":"10.13039\/501100015286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s13258-025-01701-3","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:34:08Z","timestamp":1761932048000},"page":"1343-1353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Triptonide suppresses the FOXK1\/AKT2 axis to reverse malignant phenotype and improve cisplatin efficacy in esophageal squamous cell carcinoma"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7914-2762","authenticated-orcid":false,"given":"Xiaoxu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"1701_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","volume":"21","author":"JA Ajani","year":"2023","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P et al (2023) Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 21:393\u2013422","journal-title":"J Natl Compr Canc Netw"},{"key":"1701_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","volume":"15","author":"KO Alfarouk","year":"2015","unstructured":"Alfarouk KO, Stock CM, Taylor S, Walsh M, Muddathir AK, Verduzco D et al (2015) Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int 15:71","journal-title":"Cancer Cell Int"},{"key":"1701_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","volume":"64","author":"M Arnold","year":"2015","unstructured":"Arnold M, Soerjomataram I, Ferlay J, Forman D (2015) Global incidence of oesophageal cancer by histological subtype in 2012. Gut 64:381\u2013387","journal-title":"Gut"},{"key":"1701_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"1701_CR5","doi-asserted-by":"publisher","first-page":"32779","DOI":"10.1038\/srep32779","volume":"6","author":"J Chinison","year":"2016","unstructured":"Chinison J, Aguilar JS, Avalos A, Huang Y, Wang Z, Cameron DJ et al (2016) Triptonide effectively inhibits Wnt\/beta-catenin signaling via C-terminal transactivation domain of beta-catenin. Sci Rep 6:32779","journal-title":"Sci Rep"},{"key":"1701_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.freeradbiomed.2019.03.009","volume":"135","author":"A Cruz-Bermudez","year":"2019","unstructured":"Cruz-Bermudez A, Laza-Briviesca R, Vicente-Blanco RJ, Garcia-Grande A, Coronado MJ, Laine-Menendez S et al (2019) Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1alpha in NSCLC which can be overcome by OXPHOS inhibition. Free Radic Biol Med 135:167\u2013181","journal-title":"Free Radic Biol Med"},{"key":"1701_CR7","first-page":"1681","volume":"8","author":"Y Cui","year":"2015","unstructured":"Cui Y, Lin J, Zuo J, Zhang L, Dong Y, Hu G et al (2015) AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo. Onco Targets Ther 8:1681\u20131690","journal-title":"Onco Targets Ther"},{"key":"1701_CR8","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11730","author":"Y Feng","year":"2021","unstructured":"Feng Y, Bai Z, Song J, Zhang Z (2021) FOXK1 plays an oncogenic role in the progression of hilar cholangiocarcinoma. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2020.11730","journal-title":"Mol Med Rep"},{"key":"1701_CR9","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.22926.1","author":"K Harada","year":"2020","unstructured":"Harada K, Rogers JE, Iwatsuki M, Yamashita K, Baba H, Ajani JA (2020) Recent advances in treating oesophageal cancer. F1000Res. https:\/\/doi.org\/10.12688\/f1000research.22926.1","journal-title":"F1000Res"},{"key":"1701_CR10","doi-asserted-by":"publisher","first-page":"11576","DOI":"10.18632\/oncotarget.2596","volume":"5","author":"B Li","year":"2014","unstructured":"Li B, Li J, Xu WW, Guan XY, Qin YR, Zhang LY et al (2014) Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K\/AKT pathway. Oncotarget 5:11576\u201311587","journal-title":"Oncotarget"},{"key":"1701_CR11","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1038\/s41598-023-34979-y","volume":"13","author":"X Li","year":"2023","unstructured":"Li X, Lu J, Liu L, Li F, Xu T, Chen L et al (2023) FOXK1 regulates malignant progression and radiosensitivity through direct transcriptional activation of CDC25A and CDK4 in esophageal squamous cell carcinoma. Sci Rep 13:7737","journal-title":"Sci Rep"},{"key":"1701_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z et al (2020) PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis 11:797","journal-title":"Cell Death Dis"},{"key":"1701_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00018-022-04131-6","volume":"79","author":"M Lohan-Codeco","year":"2022","unstructured":"Lohan-Codeco M, Barambo-Wagner ML, Nasciutti LE, Ribeiro Pinto LF, Meireles Da Costa N, Palumbo A Jr (2022) Molecular mechanisms associated with chemoresistance in esophageal cancer. Cell Mol Life Sci 79:116","journal-title":"Cell Mol Life Sci"},{"key":"1701_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030765","author":"M Sheikh","year":"2023","unstructured":"Sheikh M, Roshandel G, McCormack V, Malekzadeh R (2023) Current status and future prospects for esophageal cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15030765","journal-title":"Cancers (Basel)"},{"key":"1701_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12916-023-03243-5","volume":"22","author":"H Shi","year":"2024","unstructured":"Shi H, Tan Z, Duan B, Guo C, Li C, Luan T et al (2024) LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated beta-catenin dephosphorylation in a subset of stem-like bladder cancer cells. BMC Med 22:19","journal-title":"BMC Med"},{"key":"1701_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ddr.21924","volume":"83","author":"T Shi","year":"2022","unstructured":"Shi T, Li R, Duan P, Guan Y, Zhang D, Ding Z et al (2022) TRPM2-AS promotes paclitaxel resistance in prostate cancer by regulating FOXK1 via sponging miR-497-5p. Drug Dev Res 83:967\u2013978","journal-title":"Drug Dev Res"},{"key":"1701_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114705","volume":"162","author":"J Song","year":"2023","unstructured":"Song J, He GN, Dai L (2023a) A comprehensive review on celastrol, triptolide and triptonide: insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes. Biomed Pharmacother 162:114705","journal-title":"Biomed Pharmacother"},{"key":"1701_CR18","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1111\/1759-7714.15094","volume":"14","author":"K Song","year":"2023","unstructured":"Song K, Ma C, Gu B, Wang B, Ma H, Deng X et al (2023b) Molecular mechanism underlying epithelial-mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma. Thorac Cancer 14:3069\u20133079","journal-title":"Thorac Cancer"},{"key":"1701_CR19","doi-asserted-by":"publisher","first-page":"6928","DOI":"10.7150\/thno.43811","volume":"10","author":"H Sun","year":"2020","unstructured":"Sun H, Wang H, Wang X, Aoki Y, Wang X, Yang Y et al (2020) Aurora-A\/SOX8\/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells. Theranostics 10:6928\u20136945","journal-title":"Theranostics"},{"key":"1701_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s10388-020-00794-x","volume":"18","author":"M Takahashi","year":"2021","unstructured":"Takahashi M, Kato K, Okada M, Chin K, Kadowaki S, Hamamoto Y et al (2021) Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3). Esophagus 18:90\u201399","journal-title":"Esophagus"},{"key":"1701_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM (2019) A view on drug resistance in cancer. Nature 575:299\u2013309","journal-title":"Nature"},{"key":"1701_CR22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3389\/fcell.2020.00840","volume":"8","author":"L Wang","year":"2020","unstructured":"Wang L, Ji XB, Wang LH, Qiu JG, Zhou FM, Liu WJ et al (2020) Regulation of MicroRNA-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer. Front Cell Dev Biol 8:840","journal-title":"Front Cell Dev Biol"},{"key":"1701_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10142-024-01402-2","volume":"24","author":"W Wang","year":"2024","unstructured":"Wang W, Zhao X, Zhou J, Li H (2024) A novel antitumor mechanism of triptonide in colorectal cancer: inducing ferroptosis via the SLC7A11\/GPX4 axis. Funct Integr Genomics 24:126","journal-title":"Funct Integr Genomics"},{"key":"1701_CR24","doi-asserted-by":"publisher","first-page":"114870","DOI":"10.1016\/j.taap.2019.114870","volume":"388","author":"S Xiang","year":"2020","unstructured":"Xiang S, Zhao Z, Zhang T, Zhang B, Meng M, Cao Z et al (2020) Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-kappaB signaling pathways. Toxicol Appl Pharmacol 388:114870","journal-title":"Toxicol Appl Pharmacol"},{"key":"1701_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2015808118","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Lin FT, Lin WC (2021) ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2015808118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1701_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4149\/neo_2022_221118N1112","volume":"70","author":"H Zhang","year":"2023","unstructured":"Zhang H, Mao Y, Zou X, Niu J, Jiang J, Chen X et al (2023) Triptonide inhibits growth and metastasis in HCC by suppressing EGFR\/PI3K\/AKT signaling. Neoplasma 70:94\u2013102","journal-title":"Neoplasma"},{"key":"1701_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13058-021-01488-7","volume":"23","author":"M Zhang","year":"2021","unstructured":"Zhang M, Meng M, Liu Y, Qi J, Zhao Z, Qiao Y et al (2021) Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins. Breast Cancer Res 23:116","journal-title":"Breast Cancer Res"},{"key":"1701_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2019.01.002","volume":"365","author":"M Zhang","year":"2019","unstructured":"Zhang M, Tan S, Yu D, Zhao Z, Zhang B, Zhang P et al (2019) Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway. Toxicol Appl Pharmacol 365:1\u20138","journal-title":"Toxicol Appl Pharmacol"},{"key":"1701_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143467","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Hong X, Chen X, Hu C, Lu W, Xie B et al (2021) Deregulation of Exo70 facilitates innate and acquired cisplatin resistance in epithelial ovarian cancer by promoting cisplatin efflux. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13143467","journal-title":"Cancers (Basel)"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-025-01701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-025-01701-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-025-01701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T11:49:31Z","timestamp":1765194571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-025-01701-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1701"],"URL":"https:\/\/doi.org\/10.1007\/s13258-025-01701-3","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all participants involved in the study. The Ethics Committee of the Fourth Hospital of Hebei Medical University granted approval for this study (No. 2022KY409).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}